Publication | Closed Access

Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Outcomes with Nivolumab in Pretreated Non-Small Cell Lung Cancer (NSCLC): A Large Retrospective Multicenter Study

MedicineImmunologyHematologyPathologyImmune Checkpoint InhibitorNeutrophil-to-lymphocyte RatioPlatelet-to-lymphocyte RatioCancer TreatmentOncologyRadiation OncologyLung CancerHealth Sciences